Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 4/2017

01-04-2017 | Original Contributions

Biliopancreatic Diversion Decreases Postprandial Apolipoprotein A-IV Levels in Mildly Obese Individuals with Type 2 Diabetes Mellitus: a Prospective Study

Authors: Everton Cazzo, José Carlos Pareja, Bruno Geloneze, Elinton Adami Chaim, Maria Rita Lazzarini Barreto, Daniéla Oliveira Magro

Published in: Obesity Surgery | Issue 4/2017

Login to get access

Abstract

Background

Bariatric surgery usually leads to improvement on the general lipid profile, but its role in the levels of apolipoprotein A-IV (Apo-AIV) is not completely understood. Apo-AIV is a gut-released lipoprotein which is enrolled in satiety regulation and presents anti-inflammatory, anti-atherogenic, and anti-oxidative properties. The objective of this study was to determine the influence of biliopancreatic diversion (BPD) in the levels of Apo-AIV.

Methods

This is a prospective exploratory study which evaluated eight obese individuals with type 2 diabetes mellitus (T2DM) who underwent BPD (Scopinaro operation) and were followed-up for 12 months. Apo-AIV levels were determined by means of serial dosages through a standard meal tolerance test (MTT) in the immediate preoperative period and then 12 months later.

Results

There was a significant change in the Apo-AIV curve following MTT before and after surgery. At 0 and 45 min, the Apo-AIV levels did not significantly differ before and after surgery; at 120 and 180 min, Apo-AIV levels were significantly lower following BPD.

Conclusions

We observed a decrease of postprandial levels of Apo-AIV following MTT in mildly obese individuals with T2DM. This finding appears to be related to the suppression in the Apo-AIV response that obese individuals tend to present. Weight reduction itself, endotoxemia, and the large segments of bypassed intestine may be enrolled in this impaired response.
Literature
1.
World Health Organization. Global status report on noncommunicable diseases 2014. Geneva: WHO; 2014. p. 1–298.
2.
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.CrossRefPubMed
3.
Jones Jr KB. The effect of gastric bypass on cholesterol, HDL, and the risk of coronary heart disease. Obes Surg. 1992;2(1):83–5.CrossRefPubMed
4.
Benaiges D, Flores-Le-Roux JA, Pedro-Botet J, et al. Impact of restrictive (sleeve gastrectomy) vs. hybrid bariatric surgery (Roux-en-Y gastric bypass) on lipid profile. Obes Surg. 2012;22(8):1268–75.CrossRefPubMed
5.
Brolin RE, Bradley LJ, Wilson AC, et al. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg. 2000;4(5):464–9.CrossRefPubMed
6.
Cazzo E, Gestic MA, Utrini MP, et al. Impact of Roux-en-Y gastric bypass on metabolic syndrome and insulin resistance parameters. Diabetes Technol Ther. 2014;16(4):262–5.CrossRefPubMedPubMedCentral
7.
8.
Kohan AB, Wang F, Lo CM, et al. ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety. Am J Physiol Gastrointest Liver Physiol. 2015;308(6):G472–81.CrossRefPubMedPubMedCentral
9.
Raffaelli M, Guidone C, Callari C, et al. Effect of gastric bypass versus diet on cardiovascular risk factors. Ann Surg. 2014;259(4):694–9.CrossRefPubMed
10.
Culnan DM, Cooney RN, Stanley B, et al. Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass. Obesity (Silver Spring). 2009;17(1):46–52.CrossRef
11.
Aminian A, Zelisko A, Kirwan JP, et al. Exploring the impact of bariatric surgery on high density lipoprotein. Surg Obes Relat Dis. 2015;11(1):238–47.CrossRefPubMed
12.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.CrossRefPubMed
13.
Garber AJ, Abrahamson MJ, Barzilay JI, et al. American association of clinical endocrinologists’ comprehensive diabetes management algorithm 2013 consensus statement—executive summary. Endocr Pract. 2013;19(3):536–57.
14.
Scopinaro N. Biliopancreatic diversion: mechanisms of action and long-term results. Obes Surg. 2006;16(6):683–9.CrossRefPubMed
15.
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.CrossRefPubMed
16.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32.CrossRefPubMed
17.
García-Unzueta MT, Fernández-Santiago R, Domínguez-Díez A, et al. Fasting plasma ghrelin levels increase progressively after biliopancreatic diversion: one-year follow-up. Obes Surg. 2005;15(2):187–90.CrossRefPubMed
18.
Garcia-Fuentes E, Garrido-Sanchez L, Garcia-Almeida JM, et al. Different effect of laparoscopic Roux-en-Y gastric bypass and open biliopancreatic diversion of Scopinaro on serum PYY and ghrelin levels. Obes Surg. 2008;18(11):1424–9.CrossRefPubMed
19.
Dib N, Kiciak A, Pietrzak P, et al. Early-effect of bariatric surgery (Scopinaro method) on intestinal hormones and adipokines in insulin resistant Wistar rat. J Physiol Pharmacol. 2013;64(5):571–7.PubMed
20.
Pardina E, López-Tejero MD, Llamas R, et al. Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients. Obes Surg. 2009;19(10):1414–23.CrossRefPubMed
21.
Ferrer F, Nazih H, Zaïr Y, et al. Postprandial changes in the distribution of apolipoprotein AIV between apolipoprotein B- and non apolipoprotein B-containing lipoproteins in obese women. Metabolism. 2003;52(12):1537–41.CrossRefPubMed
22.
Fisher RM, Burke H, Nicaud V, et al. Effect of variation in the Apo-AIV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. J Lipid Res. 1999;40(2):287–94.PubMed
23.
Vila M, Ruíz O, Belmonte M, et al. Changes in lipid profile and insulin resistance in obese patients after Scopinaro biliopancreatic diversion. Obes Surg. 2009;19(3):299–306.CrossRefPubMed
24.
Pressler JW, Haller A, Sorrell J, et al. Vertical sleeve gastrectomy restores glucose homeostasis in apolipoprotein A-IV KO mice. Diabetes. 2015;64(2):498–507.CrossRefPubMed
25.
Lingenhel A, Eder C, Zwiauer K, et al. Decrease of plasma apolipoprotein A-IV during weight reduction in obese adolescents on a low fat diet. Int J Obes Relat Metab Disord. 2004;28(11):1509–13.CrossRefPubMed
26.
Farey JE, Preda TC, Fisher OM, et al. Effect of laparoscopic sleeve gastrectomy on fasting gastrointestinal, pancreatic, and adipose-derived hormones and on non-esterified fatty acids. Obes Surg. 2016. doi:10.​1007/​s11695-016-2302-1.
27.
Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-Year Results for Weight Loss and Ghrelin. Obes Surg. 2010;20(5):535-540.
Metadata
Title
Biliopancreatic Diversion Decreases Postprandial Apolipoprotein A-IV Levels in Mildly Obese Individuals with Type 2 Diabetes Mellitus: a Prospective Study
Authors
Everton Cazzo
José Carlos Pareja
Bruno Geloneze
Elinton Adami Chaim
Maria Rita Lazzarini Barreto
Daniéla Oliveira Magro
Publication date
01-04-2017
Publisher
Springer US
Published in
Obesity Surgery / Issue 4/2017
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-016-2414-7

Other articles of this Issue 4/2017

Obesity Surgery 4/2017 Go to the issue

Original Contributions

Criteria for Inclusion of Newer Bariatric and Metabolic Procedures into the Mainstream: a Survey of 396 Bariatric Surgeons

Letter to the Editor

Quality of Life and Weight Loss in the Long Term After Gastric Bypass

Letter to the Editor

Bariatric Surgery and Liver Function Tests in Nonalcoholic Fatty Liver Disease

New Concept

Revision of Biliopancreatic Diversion for Side Effects or Insufficient Weight Loss: Codification of a New Procedure

Review Article

RYGB and Drug Disposition: How to Do Better? Analysis of Pharmacokinetic Studies and Recommendations for Clinical Practice

Original Contributions

Intraoperative Patterns of Gastric Microperfusion During Laparoscopic Sleeve Gastrectomy